An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece.
Giannis MountziosSofia LampakiGeorgia-Angeliki KoliouAthanassios VozikisIoannis KontogiorgosPanagiotis PapantoniouMargarita-Ioanna KoufakiEleni ResAnastasios BoutisAthina ChristopoulouNicoleta PastelliAnastasios GrivasGerasimos AravantinosEfthalia LallaGeorgios OikonomopoulosAnna KoumarianouDionisios SpyratosDimitrios BafaloukosGeorgios RigakosPavlos PapakotoulasGeorge FountzilasHelena LinardouPublished in: Lung Cancer (Auckland, N.Z.) (2021)
Clinicaltrials.gov NCT04640870.